Search details
1.
Targeted Mass Spectrometry Assays for Specific Quantification of Urinary proPSA Isoforms.
J Proteome Res
; 22(3): 942-950, 2023 03 03.
Article
in English
| MEDLINE | ID: mdl-36626706
2.
Accommodating heterogeneous missing data patterns for prostate cancer risk prediction.
BMC Med Res Methodol
; 22(1): 200, 2022 07 21.
Article
in English
| MEDLINE | ID: mdl-35864460
3.
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials.
BMC Urol
; 22(1): 45, 2022 Mar 26.
Article
in English
| MEDLINE | ID: mdl-35351104
4.
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.
Int J Cancer
; 148(1): 99-105, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-32930425
5.
Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome sampling.
BMC Microbiol
; 21(1): 26, 2021 01 14.
Article
in English
| MEDLINE | ID: mdl-33446094
6.
A genome-wide association study of prostate cancer in Latinos.
Int J Cancer
; 146(7): 1819-1826, 2020 04 01.
Article
in English
| MEDLINE | ID: mdl-31226226
7.
Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools.
BMC Med Res Methodol
; 19(1): 191, 2019 10 15.
Article
in English
| MEDLINE | ID: mdl-31615451
8.
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Prostate
; 77(8): 908-919, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28317149
9.
MBDDiff: an R package designed specifically for processing MBDcap-seq datasets.
BMC Genomics
; 17 Suppl 4: 432, 2016 08 18.
Article
in English
| MEDLINE | ID: mdl-27556923
10.
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.
Prostate
; 76(12): 1120-9, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27197965
11.
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Prostate
; 76(6): 565-74, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26771888
12.
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
Cancer
; 122(15): 2332-40, 2016 08 01.
Article
in English
| MEDLINE | ID: mdl-27164191
13.
Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer.
J Urol
; 196(2): 355-60, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26979652
14.
Processing of voided urine for prostate cancer RNA biomarker analysis.
Prostate
; 75(16): 1886-95, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26306723
15.
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Prostate
; 75(13): 1403-18, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26047319
16.
DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
Prostate
; 75(15): 1790-801, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26332453
17.
Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculator.
J Urol
; 193(2): 460-5, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25242395
18.
Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen Screening.
J Urol
; 194(1): 46-51, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25686543
19.
Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing.
J Urol
; 194(3): 680-4, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25636657
20.
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators.
J Biomed Inform
; 56: 87-93, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25989018